Background Radioactive iodine 131 ( 131 I) therapy has long been used in the treatment of
differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications …

Background Thyroid gland lacks squamous epithelium (except in some rare situations like
embroyonic remnants or in inflammatory processes); for that reason the primary squamous …

Background: Aim was to evaluate the dose distribution within the thyroid gland its association
with hypothyroidism in breast cancer (BC) patients receiving supraclavicular (SC) radiation …

Background The aim was to evaluate whether extended-field concurrent chemoradiation (EF-CCRT)
leads to results better than those obtained by standard whole-pelvis concurrent …

Background Papillary Microcarcinoma (PMC) of thyroid is a rare type of differentiated thyroid
cancer (DTC), which according to the World Health Organization measures 1.0 cm or less. …

Background A meta-analysis was conducted to assess the impact of radiopharmaceuticals (RPs)
in castration-resistant prostate cancer (CRPC) on pain control, symptomatic skeletal …

Background To evaluate the dose distribution to the lumbosacral plexus (LSP) and its correlation
with radiation-induced lumbosacral plexopathy (RILSP) in patients with cervical cancer …

Introduction Age is an important prognostic factor in differentiated thyroid cancer (DTC). Our
aim was to evaluate differences in clinicopathological features and treatment outcomes …

Hemangiopericytoma (HPC) is a rare tumor of uncertain malignant potential arising from
mesenchymal cells with pericytic differentiation. It accounts for 3-5% of soft tissue sarcomas and …

Introduction The aim of this study was to evaluate the treatment outcomes of differentiated
thyroid cancer in Saudi patients aged above 60 years. Materials and methods Comparative …